Chiba, Japan

Aki Yokomizo




Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Aki Yokomizo: Innovator in Pharmaceutical Chemistry

Introduction: Aki Yokomizo, a dedicated inventor based in Chiba, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a focus on developing effective antibiotics, Yokomizo has been granted three patents, reflecting his commitment to innovation and research.

Latest Patents: Aki Yokomizo's latest patents include innovative compounds designed to improve antibiotic efficacy. One notable patent is for an amino group-containing pyrrolidinone derivative, which presents a novel compound represented by a specific formula. Another critical development is an imidazole carbonyl compound aimed at creating an antibiotic with a unique mechanism of action. This antibiotic is characterized by its low cytotoxicity, high solubility in water, and the ability to inhibit DNA gyrase GyrB and topoisomerase IV ParE subunits. Yokomizo’s work emphasizes the synthesis of a pharmaceutical composition, including pharmacologically acceptable salts or prodrugs, specifically for treating infectious diseases.

Career Highlights: Currently, Aki Yokomizo is a researcher at Daiichi Sankyo Company, Limited, where he applies his expertise to the development of groundbreaking antibiotics. His approach combines innovative chemistry with a deep understanding of pharmacology, allowing him to create compounds that address critical healthcare needs.

Collaborations: Working alongside talented coworkers such as Tetsunori Fujisawa and Tsuyoshi Soneda, Yokomizo engages in collaborative efforts that enhance the scope and impact of their research. Together, they strive to push the boundaries of pharmaceutical innovation, contributing to advancements in the medical field.

Conclusion: Aki Yokomizo stands out as a prominent figure in pharmaceutical innovation. With three patents to his name and a clear focus on addressing pressing medical challenges, he exemplifies the spirit of invention that drives progress in the industry. Continued collaboration and research in his field will no doubt lead to further breakthroughs, improving treatments for infectious diseases and enhancing public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…